Marco Cavaleri is Head of Office, Health Threats and vaccines strategy. He is the Chair of EMA COVID-19 Task Force (ETF) and responsible for EMA activities for emergent pathogens, vaccines and AMR.
He serves in different advisory groups at WHO, including PDVAC, AMR priority pathogens and R&D Blueprint SAG and clinical trials working group.
Marco Cavaleri is a Pharmacologist who spent several years in industry in R&D mainly in the area of anti-infectives covering different positions in preclinical and clinical development of new antibacterial, antitubercular and antifungal agents.
He has been driving the EMA AMR strategy on human medicines since 2009 including the international partnerships that lead to alignment of clinical trials requirements for new antibacterial agents with FDA, PMDA and HC.
He is co-author of several publications related to AMR, TB, antibiotics, vaccines and phages.